Abstract
The reliable detection of ligand and analyte binding is of significant importance for the field of medical diagnostics. Recent advances in proteomics and the rapid expansion in the number of identified protein biomarkers enhance the need for reliable techniques for their identification in complex samples. Surface plasmon resonance imaging (SPRi) provides label-free detection of this binding process in real-time. This chapter details the fabrication of an SPR imaging instrument and its use in analyzing molecular binding interactions with the use of a high-density microfluidic SPRi chip, capable of multiplexed analysis as well as various immobilization chemistries. Controlled recovery of bound biomarkers is demonstrated to enable their identification using mass spectrometry. Finally, activated leukocyte cell adhesion molecule (ALCAM), a protein biomarker associated with a variety of cancers, is identified from human crude cell lysates using the microfluidic surface plasmon resonance imaging (SPRi) instrument.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Piliarik M, Vaisocherová H, Homola J (2005) A new surface plasmon resonance sensor for high-throughput screening applications. Biosens Bioelectron 20:2104–2110
Wassaf D, Kuang G, Kopacz K, Wu Q-L, Nguyen Q, Toews M, Cosic J, Jacques J, Wiltshire S, Lambert J, Pazmany CC, Hogan S, Ladner RC, Nixon AE, Sexton DJ (2006) High-throughput affinity ranking of antibodies using surface plasmon resonance microarrays. Anal Biochem 351:241–253
Shumaker-Parry JS, Aebersold R, Campbell CT (2004) Parallel, quantitative measurement of protein binding to a 120-element double-stranded DNA array in real time using surface plasmon resonance microscopy. Anal Chem 76:2071–2082
Boozer C, Kim G, Cong S, Guan H, Londergan T (2006) Looking towards label-free biomolecular interaction analysis in a high-throughput format: a review of new surface plasmon resonance technologies. Curr Opin Biotechnol 17:400–405
Luo Y, Yu F, Zare RN (2008) Microfluidic device for immunoassays based on surface plasmon resonance imaging. Lab Chip 8:694–700
Rothenhausler B, Knoll W (1988) Surface–plasmon microscopy. Nature 332:615–617
Yeatman E, Ash EA (1987) Surface plasmon microscopy. Electron Lett 23:1091–1092
Campbell CT, Kim G (2007) SPR microscopy and its applications to high-throughput analyses of biomolecular binding events and their kinetics. Biomaterials 28:2380–2392
Homola J, Yee SS, Gauglitz G (1999) Surface plasmon resonance sensors: review. Sens Actuators B Chem 54:3–15
Shumaker-Parry JS, Zareie MH, Aebersold R, Campbell CT (2004) Microspotting streptavidin and double-stranded DNA arrays on gold for high-throughput studies of protein-DNA interactions by surface plasmon resonance microscopy. Anal Chem 76:918–929
Li Y, Wark AW, Lee HJ, Corn RM (2006) Single-nucleotide polymorphism genotyping by nanoparticle-enhanced surface plasmon resonance imaging measurements of surface ligation reactions. Anal Chem 78:3158–3164
Malic L, Veres T, Tabrizian M (2009) Biochip functionalization using electrowetting-on-dielectric digital microfluidics for surface plasmon resonance imaging detection of DNA hybridization. Biosens Bioelectron 24:2218–2224
Goodrich TT, Lee HJ, Corn RM (2004) Direct detection of genomic DNA by enzymatically amplified SPR imaging measurements of RNA microarrays. J Am Chem Soc 126:4086–4087
Wegner GJ, Lee HJ, Marriott G, Corn RM (2003) Fabrication of histidine-tagged fusion protein arrays for surface plasmon resonance imaging studies of protein–protein and protein–DNA interactions. Anal Chem 75:4740–4746
Li Y, Lee HJ, Corn RM (2007) Detection of protein biomarkers using RNA aptamer microarrays and enzymatically amplified surface plasmon resonance imaging. Anal Chem 79:1082–1088
Wegner GJ, Lee HJ, Corn RM (2002) Characterization and optimization of peptide arrays for the study of epitope–antibody interactions using surface plasmon resonance imaging. Anal Chem 74:5161–5168
Lee K-H, Su Y-D, Chen S-J, Tseng F-G, Lee G-B (2007) Microfluidic systems integrated with two-dimensional surface plasmon resonance phase imaging systems for microarray immunoassay. Biosens Bioelectron 23:466–472
Lausted CG, Hu Z, Hood LE (2008) Quantitative serum proteomics from surface plasmon resonance imaging. Mol Cell Proteomics 7(12):2464–2474
Fu E, Chinowsky T, Nelson K, Johnston K, Edwards T, Helton K, Grow M, Miller JW, Yager P (2007) SPR imaging-based salivary diagnostics system for the detection of small molecule analytes. Ann N Y Acad Sci 1098:335–344
Rich RL, Myszka DG (2007) Higher-throughput, label-free, real-time molecular interaction analysis. Anal Biochem 361:1–6
Bravman T, Bronner V, Lavie K, Notcovich A, Papalia GA, Myszka DG (2006) Exploring “one-shot” kinetics and small molecule analysis using the ProteOn XPR36 array biosensor. Anal Biochem 358:281–288
Stroock AD, Dertinger SKW, Ajdari A, Mezic I, Stone HA, Whitesides GM (2002) Chaotic mixer for microchannels. Science 295:647–651
Rich RL, Cannon MJ, Jenkins J, Pandian P, Sundaram S, Magyar R, Brockman J, Lambert J, Myszka DG (2008) Extracting kinetic rate constants from surface plasmon resonance array systems. Anal Biochem 373:112–120
Barry R, Ivanov D (2004) Microfluidics in biotechnology. J Nanobiotechnol 2:2
Bange A, Halsall HB, Heineman WR (2005) Microfluidic immunosensor systems. Biosens Bioelectron 20:2488–2503
deMello AJ (2006) Control and detection of chemical reactions in microfluidic systems. Nature 442:394–402
Khandurina J, Guttman A (2002) Bioanalysis in microfluidic devices. J Chromatogr A 943:159–183
Wang Z, Wilkop T, Xu D, Dong Y, Ma G, Cheng Q (2007) Surface plasmon resonance imaging for affinity analysis of aptamer–protein interactions with PDMS microfluidic chips. Anal Bioanal Chem 389:819–825
Ouellet E, Lausted C, Lin T, Yang CWT, Hood L, Lagally ET (2010) Parallel microfluidic surface plasmon resonance imaging arrays. Lab Chip 10:581–588
Burkhardt M, Mayordomo E, Winzer K-J, Fritzsche F, Gansukh T, Pahl S, Weichert W, Denkert C, Guski H, Dietel M, Kristiansen G (2006) Cytoplasmic overexpression of ALCAM is prognostic of disease progression in breast cancer. J Clin Pathol 59:403–409
Vaisocherová H, Faca VM, Taylor AD, Hanash S, Jiang S (2009) Comparative study of SPR and ELISA methods based on analysis of CD166/ALCAM levels in cancer and control human sera. Biosens Bioelectron 24:2143–2148
Kristiansen G, Pilarsky C, Wissmann C, Stephan C, Weissbach L, Loy V, Loening S, Dietel M, Rosenthal A (2003) ALCAM/CD166 is up-regulated in low-grade prostate cancer and progressively lost in high-grade lesions. Prostate 54:34–43
Faca VM, Song KS, Wang H, Zhang Q, Krasnoselsky AL, Newcomb LF, Plentz RR, Gurumurthy S, Redston MS, Pitteri SJ, Pereira-Faca SR, Ireton RC, Katayama H, Glukhova V, Phanstiel D, Brenner DE, Anderson MA, Misek D, Scholler N, Urban ND, Barnett MJ, Edelstein C, Goodman GE, Thornquist MD, McIntosh MW, DePinho RA, Bardeesy N, Hanash SM (2008) A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med 5:e123
Pitteri SJ, JeBailey L, Faça VM, Thorpe JD, Silva MA, Ireton RC, Horton MB, Wang H, Pruitt LC, Zhang Q, Cheng KH, Urban N, Hanash SM, Dinulescu DM (2009) Integrated proteomic analysis of human cancer cells and plasma from tumor bearing mice for ovarian cancer biomarker discovery. PLoS One 4:e7916
Rosso O, Piazza T, Bongarzone I, Rossello A, Mezzanzanica D, Canevari S, Orengo AM, Puppo A, Ferrini S, Fabbi M (2007) The ALCAM shedding by the metalloprotease ADAM17/TACE is involved in motility of ovarian carcinoma cells. Mol Cancer Res 5:1246–1253
van Kempen LCLT, van den Oord JJ, van Muijen GNP, Weidle UH, Bloemers HPJ, Swart GWM (2000) Activated leukocyte cell adhesion molecule/CD166, a marker of tumor progression in primary malignant melanoma of the skin. Am J Pathol 156:769–774
Rappsilber J, Ishihama Y, Mann M (2002) Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 75:663–670
Acknowledgments
The authors would like to thank Dr. Leonard Foster for his advice and continued support, Dr. Leroy Hood and Christopher Lausted for their contributions to the microfluidic device design, Anders Riss Kristensen for his technical assistance with HeLa cell culture and Dr. Robert Parker for technical assistance with mass spectrometry analysis. Microfabrication was performed in the UBC Nanolab.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media,LLC
About this protocol
Cite this protocol
Ouellet, E., Lund, L., Lagally, E.T. (2013). Multiplexed Surface Plasmon Resonance Imaging for Protein Biomarker Analysis. In: Jenkins, G., Mansfield, C. (eds) Microfluidic Diagnostics. Methods in Molecular Biology, vol 949. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-62703-134-9_30
Download citation
DOI: https://doi.org/10.1007/978-1-62703-134-9_30
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-62703-133-2
Online ISBN: 978-1-62703-134-9
eBook Packages: Springer Protocols